BioCardia, Inc. (BCDA) Earning

NASDAQ Currency in USD Disclaimer

$1.99

north_east $0.15 (8.35%)
Day's range
$1.88
Day's range
$2.06

BioCardia, Inc. Analyst EPS Estimates

Quarter Number of Estimates Low Estimate High Estimate Average Estimate
Q1 2024 1 -$0.10 -$0.10 -$0.10
Q2 2024 1 -$1.19 -$1.19 -$1.19
Q3 2024 1 -$0.87 -$0.87 -$0.87

BioCardia, Inc. Earnings Date And Information

BioCardia, Inc. last posted its earnings results on Wednesday, November 13th, 2024. The company reported $-0.61 earnings per share for the quarter, topping analysts' consensus estimates of $-1.19 by $0.58. The company had revenue of 0 for the quarter and had revenue of 477,000 for the year. BioCardia, Inc. has generated $-8 earnings per share over the last year ($-8.19 diluted earnings per share) and currently has a price-to-earnings ratio of -0.72. BioCardia, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 26th, 2025 based on prior year's report dates.

BioCardia, Inc. Earnings History by Quarter

Date Quarter Consensus Estimate Reported EPS Beat/Miss Revenue Estimate Actual Revenue
11/13/2024 Q3 2024 -$1.19 -$0.61 0.58 $200,000 $0
08/13/2024 Q2 2024 -$0.10 -$0.88 -0.78 $50,000 $3,000
05/14/2024 Q1 2024 -$3.00 -$1.35 1.65 $55,000
03/27/2024 Q4 2023 -$1.65 -$1.38 0.27 $13,000
11/08/2023 Q3 2023 -$1.80 -$1.79 0.01 $50,000 $357,000
08/09/2023 Q2 2023 -$2.25 -$2.52 -0.27 $183,500 $43,000
05/10/2023 Q1 2023 -$1.95 -$2.60 -0.65 $64,000
05/01/2023 Q4 2022 -$2.49 $106,000
11/09/2022 Q3 2022 -$3.45 -$2.57 0.88 $113,000 $212,000
08/10/2022 Q2 2022 -$4.20 -$2.12 2.08 $92,000 $974,000
05/11/2022 Q1 2022 -$2.25 -$2.92 -0.67 $60,000
03/29/2022 Q4 2021 -$3.15 -$3.05 0.1 $79,000
11/10/2021 Q3 2021 -$0.21 -$2.38 -2.17 $30,000 $821,000
08/12/2021 Q2 2021 -$3.15 -$3.07 0.08 $33,500 $69,000
05/13/2021 Q1 2021 -$3.15 -$2.69 0.46 $46,000
03/30/2021 Q4 2020 -$4.65 -$3.37 1.28 $46,000
11/10/2020 Q3 2020 -$4.20 -$4.57 -0.37 $83,000 $34,000
08/13/2020 Q2 2020 -$3.75 -$6.95 -3.2 $179,000 $27,000
05/15/2020 Q1 2020 -$4.80 -$10.09 -5.29 $38,000
04/09/2020 Q4 2019 -$0.51 -$7.69 -7.18 $215,000
 

BioCardia, Inc. Earnings: FAQ's

When is BioCardia, Inc.'s earnings date?

BioCardia, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 26th, 2025 based off last year's report dates.

Did BioCardia, Inc. beat their earnings estimates last quarter?

In the previous quarter, BioCardia, Inc. (:BCDA) reported $-0.61 earnings per share (EPS) to beat the analysts' consensus estimate of $-1.19 by $0.58.

How can I listen to BioCardia, Inc.'s earnings conference call?

The conference call for BioCardia, Inc.'s latest earnings report can be listened to online.

How can I read BioCardia, Inc.'s conference call transcript?

The conference call transcript for BioCardia, Inc.'s latest earnings report can be read online.

How much revenue does BioCardia, Inc. generate each year?

BioCardia, Inc. (:BCDA) has a recorded annual revenue of $477,000.

How much profit does BioCardia, Inc. generate each year?

BioCardia, Inc. (:BCDA) has a recorded net income of $477,000. BioCardia, Inc. has generated $-8.19 earnings per share over the last four quarters.

What is BioCardia, Inc.'s price-to-earnings ratio?

BioCardia, Inc. (:BCDA) has a price-to-earnings ratio of -0.72 and price/earnings-to-growth ratio is -0.03.

Portfolio Sync
Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED